Invivocue is a bioscience company that aims to support medical and pharmaceutical research through it’s humanised rodent models. Invivocue was formed as a joint venture between Invitrocue, an innovative life sciences company providing in vitro liver models for drug toxicology testing, as well as 3D patient-derived organoid technology for personalised oncology, and Dr Chen Qing Feng, a Principal Investigator at A*STAR Singapore, Institute of Molecular and Cell Biology, whose research expertise focused on humanised mouse models for various disease applications.